找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Diagnostic and Therapeutic Advances in Hematologic Malignancies; Martin S. Tallman,Leo I. Gordon Book 1999 Springer Science+Business Media

[復制鏈接]
查看: 12123|回復: 57
樓主
發(fā)表于 2025-3-21 16:15:30 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies
編輯Martin S. Tallman,Leo I. Gordon
視頻videohttp://file.papertrans.cn/271/270736/270736.mp4
叢書名稱Cancer Treatment and Research
圖書封面Titlebook: Diagnostic and Therapeutic Advances in Hematologic Malignancies;  Martin S. Tallman,Leo I. Gordon Book 1999 Springer Science+Business Media
出版日期Book 1999
關鍵詞AIDS; bone marrow; cell; classification; leukemia; lymphoma; molecular biology; molecular medicine; stem cel
版次1
doihttps://doi.org/10.1007/b102331
isbn_softcover978-1-4757-8267-7
isbn_ebook978-0-585-38571-6Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightSpringer Science+Business Media New York 1999
The information of publication is updating

書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies影響因子(影響力)




書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies影響因子(影響力)學科排名




書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies網(wǎng)絡公開度




書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies網(wǎng)絡公開度學科排名




書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies被引頻次




書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies被引頻次學科排名




書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies年度引用




書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies年度引用學科排名




書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies讀者反饋




書目名稱Diagnostic and Therapeutic Advances in Hematologic Malignancies讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 23:16:05 | 只看該作者
0927-3042 Overview: 978-1-4757-8267-7978-0-585-38571-6Series ISSN 0927-3042 Series E-ISSN 2509-8497
板凳
發(fā)表于 2025-3-22 02:28:42 | 只看該作者
地板
發(fā)表于 2025-3-22 07:12:41 | 只看該作者
5#
發(fā)表于 2025-3-22 12:30:19 | 只看該作者
Ziming Zheng,Andrew A. Chien,Keita Teranishiproliferative disease arising in immunocompromised populations, in Hodgkin’s disease, and in peripheral T-cell lymphoma. The association is of interest in terms of the pathogenesis of these tumors and is becoming important in terms of new approaches to treatment. The purpose of this chapter is to re
6#
發(fā)表于 2025-3-22 13:06:40 | 只看該作者
https://doi.org/10.1007/978-3-319-17353-5n of either B or T lymphocytes but differing in clinical presentation, prognosis, and treatment strategies. In 1997, the estimated number of new cases of NHL was 53,600, with a slight preponderance toward males (M/F ratio: 1.3).. The estimated number of deaths secondary to NHL was 23,800 (44.4%) in
7#
發(fā)表于 2025-3-22 19:29:56 | 只看該作者
8#
發(fā)表于 2025-3-23 00:04:09 | 只看該作者
Ziming Zheng,Andrew A. Chien,Keita Teranishidistinct clinical and pathologic subtype that accounts for approximately 10% of acute myeloid leukemia (AML) cases. The unique features of APL have been well described [.–.] and include a characteristic morphologic appearance ., a reciprocal translocation between the long arms of chromosomes 15 and
9#
發(fā)表于 2025-3-23 01:34:41 | 只看該作者
10#
發(fā)表于 2025-3-23 07:59:26 | 只看該作者
Rui Pinheiro,Nuno Roma,Pedro Tomásproliferation of clonal plasma cells that are resistant to standard doses of commonly employed agents at the time of diagnosis, resulting in complete remission (CR) rates of only 5%–10% and median survival of approximately three years. This inherent resistance is probably due to an array of molecula
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 05:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
安平县| 黎川县| 荃湾区| 乌兰浩特市| 黎城县| 绥阳县| 唐海县| 当阳市| 定远县| 汉源县| 广灵县| 沛县| 仙居县| 舞钢市| 滕州市| 诸城市| 浙江省| 威海市| 峨眉山市| 松江区| 邢台市| 元江| 聂拉木县| 乌恰县| 亚东县| 科技| 会同县| 汕头市| 新沂市| 加查县| 曲松县| 阿鲁科尔沁旗| 宣城市| 沧源| 双流县| 诏安县| 兴安盟| 三台县| 历史| 石嘴山市| 荔浦县|